The Board of Directors, comprised of leading COPD experts, is GOLD’s main governing body. It encourages dissemination and adoption of the reports on COPD management through utilization of existing health care structures in individual countries and promotes international collaboration on COPD research.
Alvar G. Agusti, MD, Chair
Respiratory Institute,
Hospital Clinic, IDIBAPS
Univ. Barcelona and Ciberes
Barcelona, Spain
Richard Beasley, MD
Medical Research Institute of NZ
Wellington, New Zealand
Bartolome R. Celli, MD
Harvard Medical School
Boston, Massachusetts, USA
Rongchang Chen, MD
Shenzhen Institute of Respiratory Disease
Shenzhen People's Hospital
Shenzhen, PRC
Gerard Criner, MD
Temple University School of Medicine
Philadelphia, Pennsylvania, USA
David Halpin, MD
University of Exeter Medical School
College of Medicine and Health
University of Exeter, Exeter
Devon, UK
M. Victorina López Varela, MD
Universidad de la República
Montevideo, Uruguay
Maria Montes de Oca, MD
Hospital Universitario de Caracas
Universidad Central de Venezuela
Centro Médico de Caracas
Caracas, Venezuela
Kevin Mortimer, MD
Liverpool School of Tropical Medicine
Liverpool, UK
Sundeep Salvi MD
Pulmocare Research and Education
(PURE) Foundation
Pune, India
Claus Vogelmeier, MD
University of Marburg
Marburg, Germany
GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions: